Your browser doesn't support javascript.
loading
Parathyroid Hormone Related Peptide Hypercalcemia as a Presentation of Endometrial Clear Cell Carcinoma.
Georges, Claudia; Adhikari, Biplov; Koundaveety, Soumya; Jones, Robert; Paudel, Kalyan; Haas, Christopher.
Afiliação
  • Georges C; Department of Medicine, MedStar Health Internal Medicine Residency Program, MedStar Union Memorial Hospital, Baltimore, MD, USA.
  • Adhikari B; Department of Medicine, MedStar Health Internal Medicine Residency Program, MedStar Union Memorial Hospital, Baltimore, MD, USA.
  • Koundaveety S; Department of Medicine, MedStar Health Internal Medicine Residency Program, MedStar Union Memorial Hospital, Baltimore, MD, USA.
  • Jones R; Department of Pathology, MedStar Franklin Square Medical Center, Baltimore, MD, USA.
  • Paudel K; Department of Radiology, MedStar Harbor Hospital, Baltimore, MD, USA.
  • Haas C; Department of Internal Medicine, MedStar Franklin Square Medical Center, Baltimore, MD, USA.
Article em En | MEDLINE | ID: mdl-38596557
ABSTRACT
Hypercalcemia is a frequent complication of solid tumors and hematologic malignancies yet is only rarely associated with endometrial clear cell carcinoma. Here we report on a 70-year-old female who presented in the context of hip fracture and was incidentally found to have humoral hypercalcemia of malignancy secondary to endometrial clear cell carcinoma. This rare association makes endometrial cancer one of the differential diagnoses to be considered when assessing incidentally found symptomatic or asymptomatic hypercalcemia in the appropriate patient population.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article